SCHEMBL29705375

SCHEMBL29705375

Oc1cnc2[nH]ncc2c1

nearest known ligand 0.40

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
FGFR1 P11362 4/20 0.40
FGFR2 P21802 2/20 0.40
FGFR3 P22607 1/20 0.40
PIK3C3 Q8NEB9 3/20 0.40
BRAF P15056 1/20 0.36
CHEK1 O14757 3/20 0.35
TTBK1 Q5TCY1 1/20 0.35
TNIK Q9UKE5 1/20 0.35
AKT1 P31749 1/20 0.35
PIK3CA P42336 1/20 0.35
MAP4K4 O95819 2/20 0.34
CLK2 P49760 2/20 0.34
CDK5 Q00535 2/20 0.34
ROCK1 Q13464 2/20 0.34
DYRK1A Q13627 2/20 0.34
LRRK2 Q5S007 2/20 0.34
CLK4 Q9HAZ1 2/20 0.34
ALDH1A1 P00352 1/20 0.34
CYP1A2 P05177 1/20 0.34
CYP3A4 P08684 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL20674185 1.00 FGFR1 (0.40) FGFR1FGFR2FGFR3PIK3C3BRAF
SCHEMBL12344590 0.74 PIK3C3 (0.37) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL29705478 0.73 MAPT (0.50) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL11982852 0.73 PIK3C3 (0.36) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL15243458 0.73 NOS1 (0.50) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL10329 0.73 DYRK1A (0.50) FGFR1PIK3C3CHEK1MAP4K4CLK2
SCHEMBL3429629 0.73 PIK3C3 (0.36) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL1496196 0.73 MAPT (0.50) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL27077213 0.73 PIK3C3 (0.36) FGFR1PIK3C3BRAFCHEK1AKT1
SCHEMBL2619214 0.73 CCR1 (0.46) PIK3C3CHEK1AKT1PIK3CAALDH1A1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
WO-2025076632-A1 COMPOUNDS AND USES THEREOF FIBROCOR THERAPEUTICS INC. (CA) 2025-04-17 WO disclosed
WO-2022159745-A1 GCN2 MODULATING COMPOUNDS AND USES THEREOF HIBERCELL, INC. (US) 2022-07-28 WO disclosed